Impact of novel anti-CD11d neurotrauma therapy on leukocyte function via outside-in signalling

新型抗 CD11d 神经创伤疗法通过外向内信号传导对白细胞功能的影响

• 批准号: 449513
• 负责人: Blythe Eoin N
• 金额: $ 1.27万
• 依托单位: University of Western Ontario
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-12-01 至 2021-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=449513&lang=en
• 关键词: Antibody Therapy; Beta 2 Integrins; Cd11d/Cd18; Cell Signalling; Flow Cytometry; Fret Imaging; Nuerotrauma

Impact of novel neurotrauma therapy on white blood cell function. A novel CD11d antibody therapy has been developed at the Robarts Research Institute that improves recovery following neurotrauma. Neurotrauma includes traumatic brain and spinal cord injuri

新型神经创伤疗法对白细胞功能的影响。罗巴茨研究所开发了一种新的CD11d抗体疗法，可改善神经创伤后的康复。神经损伤包括创伤性脑损伤和脊髓损伤